MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-X(L) expression

There have been few advances in the treatment of small-cell lung cancer (SCLC) because of the lack of targets. MCL1, a member of the anti-apoptotic BCL-2 family, may be a treatment target in several cancers, including SCLC. However, whether the expression profile of the anti-apoptotic BCL-2 family a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasuda, Yuto, Ozasa, Hiroaki, Kim, Young Hak, Yamazoe, Masatoshi, Ajimizu, Hitomi, Yamamoto Funazo, Tomoko, Nomizo, Takashi, Tsuji, Takahiro, Yoshida, Hironori, Sakamori, Yuichi, Nakajima, Naoki, Menju, Toshi, Yoshizawa, Akihiko, Date, Hiroshi, Hirai, Toyohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063049/
https://www.ncbi.nlm.nih.gov/pubmed/32152266
http://dx.doi.org/10.1038/s41419-020-2379-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063049/
https://www.ncbi.nlm.nih.gov/pubmed/32152266
http://dx.doi.org/10.1038/s41419-020-2379-2

Ejemplares similares